This treatment is particularly beneficial for patients with certain types of blood cancers, such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and certain lymphomas. It can also be used for solid tumors and non-cancerous conditions like severe aplastic anemia.